Hi-Plex is a suite of methods to enable simple, accurate, and cost-effective highly multiplex PCR-based targeted sequencing (Nguyen-Dumont et al., Biotechniques 58:33–36, 2015). At its core is the principle of using gene-specific primers (GSPs) to “seed” (or target) the reaction and universal primers to “drive” the majority of the reaction. In this manner, effects on amplification efficiencies across the target amplicons can, to a large extent, be restricted to early seeding cycles. Product sizes are defined within a relatively narrow range to enable high-specificity size selection, replication uniformity across target sites (including in the context of fragmented input DNA such as that derived from fixed tumor specimens (Nguyen-Dumont et al., Biotechniques 55:69–74, 2013; Nguyen-Dumont et al., Anal Biochem 470:48–51, 2015), and application of high-specificity genetic variant calling algorithms (Pope et al., Source Code Biol Med 9:3, 2014; Park et al., BMC Bioinformatics 17:165, 2016). Hi-Plex offers a streamlined workflow that is suitable for testing large numbers of specimens without the need for automation.
This is a preview of subscription content, log in to check access.
Springer Nature is developing a new tool to find and evaluate Protocols. Learn more
The development of Hi-Plex has been supported by the Australian National Health and Medical Research Council (NHMRC) project grants 1025879 and 1108179, Cancer Council Victoria project grant 1066612 and the Victorian Life Sciences Computation Initiative (VLSCI) resource allocation VR0182.
Nguyen-Dumont T, Hammet F, Mahmoodi M et al (2015) Abridged adapter primers increase the target scope of hi-Plex. BioTechniques 58:33–36CrossRefPubMedGoogle Scholar
Nguyen-Dumont T, Pope BJ, Hammet F et al (2013) A high-plex PCR approach for massively parallel sequencing. BioTechniques 55:69–74CrossRefPubMedGoogle Scholar
Nguyen-Dumont T, Mahmoodi M, Hammet F et al (2015) Hi-Plex targeted sequencing is effective using DNA derived from archival dried blood spots. Anal Biochem 470:48–51CrossRefPubMedGoogle Scholar
Nguyen-Dumont T, Hammet F, Mahmoodi M et al (2015) Mutation screening of PALB2 in clinically ascertained families from the breast cancer family registry. Breast Cancer Res Treat 149:547–554CrossRefPubMedPubMedCentralGoogle Scholar